We are live on ! Find out more
CSII

Cardiovascular Systems, Inc.

Delisted

CSII was delisted on the 27th of April, 2023.

122 hedge funds and large institutions have $519M invested in Cardiovascular Systems, Inc. in 2014 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 40 increasing their positions, 43 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

20% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 15

2% more funds holding

Funds holding: 120122 (+2)

7% less repeat investments, than reductions

Existing positions increased: 40 | Existing positions reduced: 43

21% less capital invested

Capital invested by funds: $654M → $519M (-$135M)

25% less funds holding in top 10

Funds holding in top 10: 43 (-1)

82% less call options, than puts

Call options by funds: $153K | Put options by funds: $847K

Holders
122
Holders Change
+2
Holders Change %
+1.67%
% of All Funds
3.54%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.09%
New
18
Increased
40
Reduced
43
Closed
15
Calls
$153K
Puts
$847K
Net Calls
-$694K
Net Calls Change
-$1.01M
Name Holding Trade Value Shares
Change
Change in
Stake
Lord, Abbett & Co
26
Lord, Abbett & Co
New Jersey
$4.92M +$1.51M +52,938 +34%
Allianz Asset Management
27
Allianz Asset Management
Germany
$4.88M -$442K -15,523 -7%
NC
28
Northpointe Capital
Michigan
$4.83M -$563K -19,800 -9%
RFC
29
Russell Frank Company
Washington
$4.81M -$495K -17,417 -8%
EIM
30
Essex Investment Management
Massachusetts
$4.41M -$162K -5,712 -3%
O
31
OrbiMed
New York
$4.02M -$1.02M -36,000 -17%
Ohio Public Employees Retirement System (OPERS)
32
Ohio Public Employees Retirement System (OPERS)
Ohio
$3.99M
HM
33
HealthCor Management
New York
$3.97M +$1.81M +63,500 +61%
Geode Capital Management
34
Geode Capital Management
Massachusetts
$3.96M +$67.9K +2,387 +1%
Bank of New York Mellon
35
Bank of New York Mellon
New York
$3.35M -$390K -13,710 -9%
Renaissance Technologies
36
Renaissance Technologies
New York
$3.23M +$2.67M +93,800 +218%
NI
37
Numeric Investors
Massachusetts
$3M +$3.61M +126,824 New
OM
38
Opaleye Management
Massachusetts
$2.95M -$284K -10,000 -7%
MPI
39
Mairs & Power Inc
Minnesota
$2.64M +$3.18M +111,842 New
TCIM
40
TIAA CREF Investment Management
New York
$2.45M -$508K -17,861 -15%
PCM
41
Perkins Capital Management
Minnesota
$2.43M -$778K -27,350 -21%
ACM
42
Apex Capital Management
Ohio
$2.38M +$281K +9,896 +11%
SIA
43
Sit Investment Associates
Minnesota
$2.37M +$2.26M +79,485 +386%
DIA
44
Denver Investment Advisors
Colorado
$2.3M -$28.4K -997 -1%
TI
45
Turner Investments
Pennsylvania
$2.25M -$132K -4,630 -5%
SC
46
Sophrosyne Capital
New York
$2.17M -$31.3K -1,100 -1%
NC
47
Nicholas Company
Wisconsin
$2.15M +$2.59M +90,990 New
TA
48
Teton Advisors
New York
$2.1M
TCM
49
Timpani Capital Management
Wisconsin
$2.01M +$101K +3,561 +4%
Ameriprise
50
Ameriprise
Minnesota
$2M -$1.23M -43,283 -34%

CSII Hedge Fund Activity: Q3 2014 in Review

122 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in Cardiovascular Systems, Inc. (CSII) for Q3 2014, worth a combined $519M — down 21% from $654M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new CSII positions and 15 closed out — a net gain of 3 holders — while 40 added to existing stakes and 43 trimmed.

The largest buyer was Granahan Investment Management, adding an estimated $9.38M. The largest seller was Fidelity Investments, cutting an estimated $10.8M.

  • 122 institutional investors held Cardiovascular Systems, Inc. (CSII) as of Q3 2014, up from 120 in Q2 2014.
  • Funds reported $519M of Cardiovascular Systems, Inc. stock for Q3 2014, down 21% quarter-over-quarter.
  • 18 funds opened new Cardiovascular Systems, Inc. positions in Q3 2014 and 15 closed out, a net change of +3 holders.
  • The largest Cardiovascular Systems, Inc. buyer in Q3 2014 was Granahan Investment Management, an estimated $9.38M added.
  • The largest Cardiovascular Systems, Inc. seller in Q3 2014 was Fidelity Investments, an estimated $10.8M sold.

Based on aggregated 13F filings for Q3 2014.